相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: A systematic review and meta-analysis
Liangxia Ning et al.
PLOS ONE (2022)
Role of B Cells in Multiple Sclerosis and Related Disorders
Giancarlo Comi et al.
ANNALS OF NEUROLOGY (2021)
Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability
Rocco Capuano et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
The role of astrocyte-mediated plasticity in neural circuit development and function
Nelson A. Perez-Catalan et al.
NEURAL DEVELOPMENT (2021)
Neuronal and glial CSF biomarkers in multiple sclerosis: a systematic review and meta-analysis
Sara Momtazmanesh et al.
REVIEWS IN THE NEUROSCIENCES (2021)
First line treatment failure: Predictive factors in a cohort of 863 Relapsing Remitting MS patients
Xavier Ayrignac et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis
Franz Felix Konen et al.
CELLS (2021)
Manipulating oligodendrocyte intrinsic regeneration mechanism to promote remyelination
Fabien Biname et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Inflammation in multiple sclerosis
Stefanie Haase et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2021)
ADAMTS13 ameliorates inflammatory responses in experimental autoimmune encephalomyelitis
Kaili Lu et al.
JOURNAL OF NEUROINFLAMMATION (2020)
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study
Thais Armangue et al.
LANCET NEUROLOGY (2020)
Noninvasive Brain Delivery and Efficacy of BDNF to Stimulate Neuroregeneration and Suppression of Disease Relapse in EAE Mice
Brian M. Kopec et al.
MOLECULAR PHARMACEUTICS (2020)
Blood neurofilament light levels segregate treatment effects in multiple sclerosis
Benedicte Delcoigne et al.
NEUROLOGY (2020)
Frequency of myelin oligodendrocyte glycoprotein antibody in multiple sclerosis A multicenter cross-sectional study
Alvaro Cobo-Calvo et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
The S100B Inhibitor Pentamidine Ameliorates Clinical Score and Neuropathology of Relapsing-Remitting Multiple Sclerosis Mouse Model
Gabriele Di Sante et al.
CELLS (2020)
The role of TH17 cells in multiple sclerosis: Therapeutic implications
Tobias Moser et al.
AUTOIMMUNITY REVIEWS (2020)
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligo-dendrocyte glycoprotein antibodies: a multicentre observational study (vol 19, pg 234, 2020)
T. Armangue et al.
LANCET NEUROLOGY (2020)
Determinants of therapy switch in multiple sclerosis treatment-naive patients: A real-life study
Francesco Sacca et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
Kristin N. Varhaug et al.
FRONTIERS IN NEUROLOGY (2019)
Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
Massimo Filippi et al.
BRAIN (2019)
Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis
Wallace J. Brownlee et al.
BRAIN (2019)
IL-17A is associated with the breakdown of the blood-brain barrier in relapsing-remitting multiple sclerosis
A. Francesca Setiadi et al.
JOURNAL OF NEUROIMMUNOLOGY (2019)
Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis
Catherina Pfuhl et al.
NEUROLOGY (2019)
Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients
Zhile Bai et al.
FRONTIERS IN NEUROSCIENCE (2019)
Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort
Lina Wirestam et al.
JOURNAL OF RHEUMATOLOGY (2019)
Molecular biomarkers in multiple sclerosis
Tjalf Ziemssen et al.
JOURNAL OF NEUROINFLAMMATION (2019)
TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells
Itay Raphael et al.
JCI INSIGHT (2019)
IL-17A Promotes Granulocyte Infiltration, Myelin Loss, Microglia Activation, and Behavioral Deficits During Cuprizone-Induced Demyelination
Julian Zimmermann et al.
MOLECULAR NEUROBIOLOGY (2018)
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Fredrik Piehl et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod
Fredrik Piehl et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies
Pietro Maggi et al.
ANNALS OF NEUROLOGY (2018)
BDNF and Tau as biomarkers of severity in multiple sclerosis
Azul Islas-Hernandez et al.
BIOMARKERS IN MEDICINE (2018)
The value of oligoclonal bands in the multiple sclerosis diagnostic criteria
Georgina Arrambide et al.
BRAIN (2018)
Hemostasis biomarkers in multiple sclerosis
N. Ziliotto et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature
S. Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Impaired oligodendrogenesis and myelination by elevated S100B levels during neurodevelopment
Gisela Santos et al.
NEUROPHARMACOLOGY (2018)
Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis
Elmira Agah et al.
PLOS ONE (2018)
Serum GFAP as a biomarker for disease severity in multiple sclerosis
A. Abdelhak et al.
SCIENTIFIC REPORTS (2018)
IFN-gamma, IL-17A, or zonulin rapidly increase the permeability of the blood-brain and small intestinal epithelial barriers: Relevance for neuro-inflammatory diseases
Mohammed T. Rahman et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients
Massimiliano Castellazzi et al.
FRONTIERS IN NEUROLOGY (2018)
Multiple sclerosis: experimental models and reality
Hans Lassmann et al.
ACTA NEUROPATHOLOGICA (2017)
Personalised medicine for multiple sclerosis care
Arie Gafson et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Personalised medicine for multiple sclerosis care
Arie Gafson et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Ex-Th17 (Nonclassical Th1) Cells Are Functionally Distinct from Classical Th1 and Th17 Cells and Are Not Constrained by Regulatory T Cells
Sharee A. Basdeo et al.
JOURNAL OF IMMUNOLOGY (2017)
Anticoagulation with warfarin and rivaroxaban ameliorates experimental autoimmune encephalomyelitis
Leonie Stolz et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Defining active progressive multiple sclerosis
Finn Sellebjerg et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Glial Cells and Their Function in the Adult Brain: A Journey through the History of Their Ablation
Sarah Jakel et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2017)
Defining active progressive multiple sclerosis
Finn Sellebjerg et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Nausicaa Clemente et al.
FRONTIERS IN IMMUNOLOGY (2017)
Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in inflammatory Demyelinating Diseases
Patrick Peschl et al.
FRONTIERS IN IMMUNOLOGY (2017)
S100B as a Potential Biomarker and Therapeutic Target in Multiple Sclerosis
Andreia Barateiro et al.
MOLECULAR NEUROBIOLOGY (2016)
Reactive gliosis in the pathogenesis of CNS diseases
Milos Pekny et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training
I. Wens et al.
EUROPEAN JOURNAL OF NEUROLOGY (2016)
Glial Biomarkers in Human Central Nervous System Disease
Gwenn A. Garden et al.
GLIA (2016)
Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study
Eva Havrdova et al.
JOURNAL OF NEUROLOGY (2016)
Identification of tissue-specific cell death using methylation patterns of circulating DNA
Roni Lehmann-Werman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis
John A. Olsen et al.
EBIOMEDICINE (2016)
Defining high, medium and low impact prognostic factors for developing multiple sclerosis
Mar Tintore et al.
BRAIN (2015)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation
Rebecca A. Sosa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Recombinant ADAMTS 13 Attenuates Brain Injury After Intracerebral Hemorrhage
Ping Cai et al.
STROKE (2015)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Stage-specific role of interferon-gamma in experimental autoimmune encephalomyelitis and multiple sclerosis
Gabriel Arellano et al.
FRONTIERS IN IMMUNOLOGY (2015)
The role of astrocytes in multiple sclerosis progression
Jorge Correale et al.
FRONTIERS IN NEUROLOGY (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Role of the Blood-Brain Barrier in Multiple Sclerosis
Genaro Gabriel Ortiz et al.
ARCHIVES OF MEDICAL RESEARCH (2014)
The use of cytokine signature patterns: separating drug naive, interferon and natalizumab-treated multiple sclerosis patients
Kara E. O'Connell et al.
AUTOIMMUNITY (2014)
Th17 cells in central nervous system autoimmunity
Christopher Sie et al.
EXPERIMENTAL NEUROLOGY (2014)
Acute Biomarkers of Traumatic Brain Injury: Relationship between Plasma Levels of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein
Ramon Diaz-Arrastia et al.
JOURNAL OF NEUROTRAUMA (2014)
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status
Violaine K. Harris et al.
MOLECULAR DIAGNOSIS & THERAPY (2014)
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation
Lior Mayo et al.
NATURE MEDICINE (2014)
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders
Douglas Kazutoshi Sato et al.
NEUROLOGY (2014)
Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice
Stefan Bittner et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2014)
Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models
Amanda Boyd et al.
ACTA NEUROPATHOLOGICA (2013)
Astrocyte-Neuron Interaction at Tripartite Synapses
Alberto Pérez-Alvarez et al.
CURRENT DRUG TARGETS (2013)
Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude
Ruth Dobson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity
Levente Szalardy et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions
Enrique Alvarez et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Serum autoantibodies to myelin peptides distinguish acute disseminated encephalomyelitis from relapsing-remitting multiple sclerosis
Keith Van Haren et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
A comparative study of CSF neurofilament light and heavy chain protein in MS
Jens Kuhle et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Astrocytes differentially respond to inflammatory autoimmune insults and imbalances of neural activity
Peter Jukkola et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
Neurofilament a biomarker of neurodegeneration in autoimmune encephalomyelitis
Sharmilee Gnanapavan et al.
AUTOIMMUNITY (2012)
Inflammatory bowel disease and lupus: A systematic review of the literature
Konstantinos H. Katsanos et al.
JOURNAL OF CROHNS & COLITIS (2012)
The S100B protein in biological fluids: more than a lifelong biomarker of brain distress
Fabrizio Michetti et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Cerebrospinal hepatocyte growth factor levels correlate negatively with disease activity in multiple sclerosis
Andre Michael Mueller et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation
Markus C. Kowarik et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models
Lianhua Bai et al.
NATURE NEUROSCIENCE (2012)
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Joanna Kitley et al.
NEUROLOGY (2012)
The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system
Emily K. Rainey-Barger et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
Cris S. Constantinescu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis
M. Axelsson et al.
JOURNAL OF NEUROLOGY (2011)
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis
Lars Bornsen et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis
J. Kuhle et al.
NEUROLOGY (2011)
Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions
E. C. Tallantyre et al.
NEUROLOGY (2011)
GFAP in health and disease
J. Middeldorp et al.
PROGRESS IN NEUROBIOLOGY (2011)
Th17 Cell, the New Player of Neuroinflammatory Process in Multiple Sclerosis
F. Jadidi-Niaragh et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2011)
Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis
Ralf A. Linker et al.
BRAIN (2010)
Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells
Mahdia Benkhoucha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Effector and Regulatory T-cell Subsets in Autoimmunity and Tissue Inflammation
A. Jaeger et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
Post-transcriptional control of neurofilaments: New roles in development, regeneration and neurodegenerative disease
Ben G. Szaro et al.
TRENDS IN NEUROSCIENCES (2010)
Neuronal intermediate filaments and neurodegenerative disorders
Rodolphe Perrot et al.
BRAIN RESEARCH BULLETIN (2009)
Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle
Tapas K. Makar et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis
Jayasri Das Sarma et al.
JOURNAL OF NEUROINFLAMMATION (2009)
Reactive Astrocytes Form Scar-Like Perivascular Barriers to Leukocytes during Adaptive Immune Inflammation of the CNS
Rhonda R. Voskuhl et al.
JOURNAL OF NEUROSCIENCE (2009)
Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis
Y. Benesova et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Proteome Profiling in Murine Models of Multiple Sclerosis: Identification of Stage Specific Markers and Culprits for Tissue Damage
Ralf A. Linker et al.
PLOS ONE (2009)
The role of osteopontin in inflammatory processes
Susan Amanda Lund et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
John S. Tzartos et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis
Alireza Minagar et al.
ARCHIVES OF NEUROLOGY (2008)
Matrix Metalloproteinase-9/Gelatinase B is a Putative Therapeutic Target of Chronic Obstructive Pulmonary Disease and Multiple Sclerosis
Q.-X. Sang et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection
David Azoulay et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Chronological changes of CD4+ and CD8+ T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis
Yoshifumi Sonobe et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators
V. Wee Yong et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2007)
Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury
Kazuya Kitamura et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Excitotoxic damage to white matter
Carlos Matute et al.
JOURNAL OF ANATOMY (2007)
Lack of association between antimyelin antibodies and progression to multiple sclerosis
Jens Kuhle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis
Catherine Uyttenhove et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Yutaka Komiyama et al.
JOURNAL OF IMMUNOLOGY (2006)
CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis
Ludmila V. Bagaeva et al.
JOURNAL OF IMMUNOLOGY (2006)
Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis
S Agrawal et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Size regulation of von Willebrand factor-mediated platelet thrombi by ADAMTS13 in flowing blood
R Donadelli et al.
BLOOD (2006)
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis
E Fainardi et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment
M Krumbholz et al.
BRAIN (2006)
Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis
S Sriram et al.
ANNALS OF NEUROLOGY (2005)
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
H Park et al.
NATURE IMMUNOLOGY (2005)
Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis
M Caggiula et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)
TGF-β-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway
PH Lalive et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Plasma osteopontin levels in multiple sclerosis
M Comabella et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice
GJ Burbach et al.
JOURNAL OF NEUROSCIENCE (2004)
Neurofilament proteins in neurodegenerative diseases
Q Liu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
The cytoskeleton in neurodegenerative diseases
NJ Cairns et al.
JOURNAL OF PATHOLOGY (2004)
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event
T Berger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Gelatinase B/matrix metalloproteinase-9 cleaves interferon-β and is a target for immunotherapy
I Nelissen et al.
BRAIN (2003)
Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system
SS Yan et al.
NATURE MEDICINE (2003)
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes
C Avolio et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-β2-deficient mice:: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system
GX Zhang et al.
JOURNAL OF IMMUNOLOGY (2003)
Differential mechanisms of action of interferon-β and glatiramer acetate in MS
VW Yong
NEUROLOGY (2002)
Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells
HL Yan et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Markers for different glial cell responses in multiple sclerosis: clinical and pathological correlations
A Petzold et al.
BRAIN (2002)
Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis
C Lock et al.
NATURE MEDICINE (2002)
BDNF and gp145trkB in multiple sclerosis brain lesions: Neuroprotective interactions between immune and neuronal cells?
C Stadelmann et al.
BRAIN (2002)
The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease
D Chabas et al.
SCIENCE (2001)
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival
DT Denhardt et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
A chemokine-driven positive feedback loop organizes lymphoid follicles
KM Ansel et al.
NATURE (2000)
Glutamate excitotoxicity in a model of multiple sclerosis
D Pitt et al.
NATURE MEDICINE (2000)
分享论文
